SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022985
Filing Date
2024-09-05
Accepted
2024-09-05 19:49:11
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 form4-09052024_110908.html 4  
1 form4-09052024_110908.xml 4 9269
  Complete submission text file 0001415889-24-022985.txt   10787
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 98195-2141
Business Address
CHURCH KEVIN (Reporting) CIK: 0001822499 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 241282664